Dr Desai will guide ENTOD’s research strategies, focussing on integrating progressive methodologies to develop novel therapies in ophthalmology, ENT, and dermatology

Mumbai-based ENTOD Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser. Dr Desai, a Clinical Pharmacologist with expertise in pharmaceuticals and nutraceuticals, brings over 30 years of distinguished experience spanning academia, research, and the healthcare industry.

Dr Desai will guide ENTOD’s research strategies, focussing on integrating progressive methodologies to develop novel therapies in ophthalmology, ENT, and dermatology. His appointment comes as ENTOD strengthens its commitment to leveraging advanced technologies to create impactful healthcare solutions that address unmet patient needs. 

Dr Desai commented, “I am honoured to join ENTOD, an organisation that has consistently championed innovation in healthcare. Throughout my career, I have been driven by the pursuit of research that translates into real-world patient benefits, and I am excited to bring this ethos to ENTOD. Together, we have the potential to redefine therapeutic possibilities by blending scientific rigour with innovative approaches, ultimately contributing to the well-being of millions. I look forward to working closely with the team, building on ENTOD’s robust foundation, and steering its scientific endeavours toward even greater accomplishments.”

Nikkhil K Masurkar, CEO, ENTOD Pharma said, “Dr Desai’s extensive background in research and development, coupled with his proven ability to drive sustainable growth, positions him as a vital asset to our organisation. His strategic approach and innovative thinking will be instrumental in enhancing our R&D capabilities and shaping ENTOD’s future trajectory. We are confident that his insights will not only support our ambitious goals but also unlock new growth opportunities as we continue to deliver high-quality solutions for patients worldwide.”